Medicare Enrolled
Dr. Edward Crane, MD
Hematology & Oncology · Fairfield, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Crane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Crane?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Crane
Dr. Edward Crane is a hematology & oncology specialist in Fairfield, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Crane performed 1,330 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Crane received a total of $179,765 from 61 pharmaceutical and/or device companies across 352 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Crane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 26% volume in OH
$179,765 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,330
Medicare services
Top 26% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
632 | $103 | $366 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
528 | $64 | $273 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
69 | $44 | $184 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
40 | $85 | $232 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $102 | $416 |
| New patient office visit, complex (60-74 min) | 20 | $125 | $522 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
15 | $22 | $28 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$179,765
Total received (2018-2024)
Avg $25,681/year across 7 years
Top 6% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
352
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$26,257
2023
$17,524
2022
$20,326
2021
$44,614
2020
$10,822
2019
$38,064
2018
$22,158
Payments by company (2024)
Daiichi Sankyo Inc.
$12,613
AstraZeneca Pharmaceuticals LP
$9,111
E.R. Squibb & Sons, L.L.C.
$3,233
PFIZER INC.
$185
ABBVIE INC.
$159
Novartis Pharmaceuticals Corporation
$129
Genentech USA, Inc.
$74
Celgene Corporation
$67
GlaxoSmithKline, LLC.
$62
Astellas Pharma US Inc
$59
Stemline Therapeutics Inc.
$41
Alexion Pharmaceuticals, Inc.
$41
Merck Sharp & Dohme LLC
$40
EMD Serono, Inc.
$38
Sumitomo Pharma America, Inc.
$36
Incyte Corporation
$29
Gilead Sciences, Inc.
$28
Ipsen Biopharmaceuticals, Inc
$24
Immunocore Limited
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
SpringWorks Therapeutics, Inc.
$20
GENZYME CORPORATION
$19
Deciphera Pharmaceuticals Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
Lilly USA, LLC
$17
Spectrum Pharmaceuticals Inc.
$17
Adaptive Biotechnologies Corporation
$16
Aveo Pharmaceuticals, Inc.
$16
Blueprint Medicines Corporation
$16
ARRAY BIOPHARMA INC
$16
Secura Bio, Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Janssen Biotech, Inc.
$15
SOBI, INC
$14
Agios Pharmaceuticals, Inc.
$13
Top 3 companies account for 95.0% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$45,848
E.R. Squibb & Sons, L.L.C.
$36,898
Genentech USA, Inc.
$35,946
AstraZeneca Pharmaceuticals LP
$30,124
Novartis Pharmaceuticals Corporation
$27,964
Pharmacyclics LLC, An AbbVie Company
$336
PFIZER INC.
$215
ABBVIE INC.
$159
Sirtex Medical Inc
$131
Seagen Inc.
$125
Celgene Corporation
$117
GlaxoSmithKline, LLC.
$113
Amgen Inc.
$102
Incyte Corporation
$90
Lilly USA, LLC
$88
Regeneron Healthcare Solutions, Inc.
$85
Merck Sharp & Dohme LLC
$79
Astellas Pharma US Inc
$77
EMD Serono, Inc.
$64
Ipsen Biopharmaceuticals, Inc
$63
Novo Nordisk Inc
$60
Stemline Therapeutics Inc.
$57
Gilead Sciences, Inc.
$55
Johnson & Johnson Surgical Vision, Inc.
$54
Sumitomo Pharma America, Inc.
$52
Pharmacyclics LLC, an AbbVie Company
$46
GENZYME CORPORATION
$42
AVEO Pharmaceuticals, Inc.
$41
Alexion Pharmaceuticals, Inc.
$41
Myovant Sciences Inc.
$39
Janssen Biotech, Inc.
$37
Blueprint Medicines Corporation
$37
TAIHO ONCOLOGY, INC.
$34
Puma Biotechnology, Inc.
$33
Secura Bio, Inc.
$31
Bayer Healthcare Pharmaceuticals Inc.
$31
Genmab U.S., Inc.
$26
TerSera Therapeutics LLC
$26
Cumberland Pharmaceuticals, Inc.
$24
Immunocore Limited
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Eisai Inc.
$20
SpringWorks Therapeutics, Inc.
$20
Rigel Pharmaceuticals, Inc.
$18
ADC Therapeutics America, Inc.
$18
Mirati Therapeutics, Inc.
$18
Deciphera Pharmaceuticals Inc.
$18
PharmaEssentia USA Corporation
$18
SERVIER PHARMACEUTICALS LLC
$17
Kyowa Kirin, Inc.
$17
JAZZ PHARMACEUTICALS INC.
$17
Spectrum Pharmaceuticals Inc.
$17
Adaptive Biotechnologies Corporation
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
Aveo Pharmaceuticals, Inc.
$16
ARRAY BIOPHARMA INC
$16
SOBI, INC
$14
Tactile Systems Technology Inc
$14
Merck Sharp & Dohme Corporation
$14
Agios Pharmaceuticals, Inc.
$13
Janssen Pharmaceuticals, Inc
$13
Top 3 companies account for 66.0% of all-time payments
Associated products mentioned in payments ›
AYVAKIT · BESREMI · BLENREP · BOSULIF · CALQUENCE · COPIKTRA · CYRAMZA · ELIQUIS · ENHERTU · EPKINLY · Enhertu · Epkinly · Esperoct · FLEXITOUCH · FOTIVDA · Fabhalta · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MONJUVI · Nerlynx · Non-Covered Product · NovoSeven · Novoeight · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · Revlimid · Rezlidhia · Rituxan · SANCUSO · SARCLISA · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · TABRECTA · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TUKYSA · Tazverik · Tecentriq · Tecnis IOL · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Venclexta · XALKORI · XARELTO · XTANDI · Xospata · YONSA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
74
County median income
$81,194
Nearest hospital to ZIP centroid (approximate)
MERCY HEALTH - FAIRFIELD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Crane is a clinical cardiology specialist, with above-average Medicare volume (top 26% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Crane experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Crane performed 632 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Crane receive payments from pharmaceutical companies?
Yes. Dr. Crane received a total of $179,765 from 61 companies across 352 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Crane's costs compare to other hematology & oncology specialists in Fairfield?
Dr. Crane's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Crane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fairfield
Browse hematology & oncology specialists in Fairfield ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology